In context it has been a little tepid insofar as the $$$ effect on the few 100 shares of XON I purchased at $31.58 in early Feb. on hearing Bill miller's statement that he regards XON as the biotech stock of the decade[CNBC, AH, 2/7/2015]. But + 51% in less than 2 months is not too bad, I guess.